Biocon launches new drug for breast cancer
Biotechnology major Biocon will start selling breast cancer drug 'CANMAb', developed jointly with US-based Mylan, in the country from next month.
READ MORE:
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
